Company intelligence / Profile preview

NeuroTrainer

San Francisco, California, United Statesneurotrainer.com ↗

Ownership: Private
Development stage: Commercial

Overview

NeuroTrainer has demonstrated measurable improvements in focus, decision-making speed, hand-eye coordination, and situational awareness among athletes. The system’s efficacy has been validated through partnerships with professional sports teams and ongoing research collaborations. It also shows promise for broader applications such as ADHD support in students and corporate wellness programs. No clinical trial results as it does not develop therapeutics.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

National Science Foundation (development partnership)LA Galaxy™ soccer team (“official cognitive training system”)Collaborations with NBA/NHL/MLB/collegiate DI teams

Beyond the preview

Go deeper on NeuroTrainer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroTrainer.

Explore the full profile